Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Late-Stage Pipeline

20%

1 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

4 recruiting

Enrollment Performance

Analytics

Phase 3
1(100.0%)
1Total
Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT06360458Phase 3Active Not Recruiting

Methylprednisolone Adjunctive to Endovascular Thrombectomy for Stroke

Role: lead

NCT04006418Recruiting

A Registered Cohort Study on Spastic Paraplegia

Role: lead

NCT04010201Recruiting

A Registered Cohort Study on Brain Calcification

Role: lead

NCT04012658Recruiting

A Registered Cohort Study on Wilson's Disease

Role: lead

NCT04010604Recruiting

A Registered Cohort Study on SMA

Role: lead

All 5 trials loaded